Evaxion Biotech (EVAX) PT Lowered to $9 at Lake Street
Lake Street analyst Thomas Flaten lowered the price target on Evaxion Biotech (NASDAQ: EVAX) to $9.00 (from $11.00) while maintaining a Buy rating.
Lake Street analyst Thomas Flaten lowered the price target on Evaxion Biotech (NASDAQ: EVAX) to $9.00 (from $11.00) while maintaining a Buy rating.